Challenge
A biotech company was looking for new funds to launch the first clinical trials.
Mission
- Funding Strategy: define the pre-money value, the current and the future needs/use of funds
- Marketing: review financial and marketing documents (financial plan, tagline, elevator pitch, executive summary, slide deck, etc.)
- Targets: list the potential investors and identify the potential lead investors
- Term Sheet: lead the negotiation (pre-money and level of funds)
- Due Diligence: finalise the data room and share the documents
- Negotiation: support and close the negotiation (pre-money valuation, shareholders agreement, notarial deeds, etc.)
Results
The company raised €35M in a series B financing round.
Key Success Factors
- Significant experience in funding and valuation
- Knowledge of the sector of activity
- Network offering a privileged access to the Belgian ecosystem
We support assets valuation and empower healthcare and digital innovation through:
- Funding Strategy
- Fundraising
- M&A
- Business and Financial Plan Review
- Deal and Due Diligence Support
- Subsidies and Grants